Molecular classification based on HPV and p53 status identifies distinct prognostic subgroups within early-stage vulvar squamous cell carcinoma (vSCC).
HPV-negative tumors with TP53 mutations exhibit significantly worse 10-year disease-specific survival and higher recurrence rates, especially groin failures.
HPV-positive tumors show excellent prognosis with high 10-year survival and low recurrence.
A tumor-free margin of ≥3 mm confers protective benefit and remains important for HPV-/p53-mutant tumors.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
